Home > Boards > US Listed > Medical - Drugs > NovaBay Pharmaceuticals, Inc. (NBY)

News: $NBY NovaBay Pharmaceuticals Names Finance Executive Jeff

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 49
Posts 6,441
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
NovaBay Pharmaceuticals Launches NovaSight™ Daily Vitamin for Ocular Health on Amazon.com Business Wire - 11/18/2019 6:50:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/7/2019 4:14:21 PM
NovaBay Pharmaceuticals Reports 2019 Third Quarter Financial Results Business Wire - 11/7/2019 4:05:00 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 11/6/2019 6:00:59 AM
NovaBay Pharmaceuticals Launches Online Sales of CelleRx® Skin Cleanser for Post-Aesthetic Dermatology & Cosmetic Surgery Pr... Business Wire - 11/4/2019 6:50:00 AM
NovaBay Pharmaceuticals to Hold Third Quarter 2019 Conference Call on November 7, 2019 Business Wire - 10/31/2019 6:50:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/30/2019 4:32:21 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 10/28/2019 4:31:11 PM
Amended Statement of Changes in Beneficial Ownership (4/a) Edgar (US Regulatory) - 10/28/2019 4:30:07 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:29:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:28:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:26:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:26:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 10/28/2019 4:25:26 PM
NovaBay Pharmaceuticals to Distribute the NuLids System® for the Treatment of Dry Eye in Certain U.S. Geographies Business Wire - 10/28/2019 6:50:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 10/25/2019 4:33:12 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/10/2019 4:31:16 PM
NovaBay Pharmaceuticals Receives Approval for Distribution of Avenova in Australia Business Wire - 9/24/2019 6:50:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/16/2019 4:31:08 PM
NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors Business Wire - 9/16/2019 6:50:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 9/13/2019 8:31:28 AM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 9/13/2019 6:01:18 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 9/4/2019 4:33:03 PM
NovaBay Pharmaceuticals to Present at Two Investment Conferences in September Business Wire - 9/3/2019 6:50:00 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 8/30/2019 4:31:48 PM
whytestocks Member Level  Monday, 09/16/19 08:20:24 AM
Re: None
Post # of 892 
News: $NBY NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova ® for the domestic eye care market, announces that Yenyou (Jeff) Zheng, Ph.D. has joined the Company’s board as an independent director. Dr. Zheng will ch...

In case you are interested NBY - NovaBay Pharmaceuticals Names Finance Executive Jeff Zheng to its Board of Directors

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist